Dual Metal Nanoflower Oxygen Pump Microneedles Based on Cuproptosis and STING Pathway Activation for Cancer Immunotherapy
Small · 2025-03 · 21 (11)
DOI: 10.1002/smll.202409187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 14.02.2025. Verfasst von Jiaojiao Tao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, Shandong Key Laboratory Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, O…. Hauptthemen laut MEDLINE: Immunotherapy, Oxygen, Neoplasms, Membrane Proteins. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Immunotherapy is a promising new approach for tumor treatment. However, its clinical application is hindered by insufficient immunogenicity, hypoxia, and immunosuppressive tumor microenvironment (TME). Here, oxygen pump microneedles (OPMNs) loaded with zinc‐doped copper sulfide nanoflowers (ZCS NFs) and PD‐L1 small interfering RNA (siPD‐L1) (OPMNs‐ZCS@siPD‐L1) are developed for boosting tumor immunotherapy. OPMN‐ZCS@siPD‐L1 enhances tumor immunogenicity through ZCS NFs by inducing cuproptosis, reverses TME through siPD‐L1, and promotes drug penetration, and ameliorates hypoxia through oxygen bubbles. More importantly, cuproptosis‐induced mitochondrial DNA (mtDNA) together with Zn 2+ co‐activate the STING pathway, triggering a robust immune response. OPMN‐ZCS@siPD‐L1 increases the sensitivity to cuproptosis and induces immunogenic cell death (ICD) in vivo and in vitro, which significantly inhibits tumor progression and metastasis. The novel strategy of “increasing the throttle” (cuproptopsis‐mediated STING activation & ICD effect) combined with “releasing the brake” (PD‐L1 inhibition & hypoxia improvement) provides a new approach for enhancing percutaneous tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, Ministry of Education, Shandong Key Laboratory Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao, 266237, China.
ORCID-Profile: Xia Zhao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Tao, J., Dong, Y., Wang, B., Wang, T., Zhang, A., Li, S., Chen, R., Su, Y., Jiang, T., & Zhao, X. (2025). Dual Metal Nanoflower Oxygen Pump Microneedles Based on Cuproptosis and STING Pathway Activation for Cancer Immunotherapy. Small, 21(11). https://doi.org/10.1002/smll.202409187
Vancouver
Tao J, Dong Y, Wang B, Wang T, Zhang A, Li S, et al. Dual Metal Nanoflower Oxygen Pump Microneedles Based on Cuproptosis and STING Pathway Activation for Cancer Immunotherapy. Small. 2025;21(11). doi:10.1002/smll.202409187
BibTeX
@article{Tao2025,
author = {Tao, Jiaojiao and Dong, Yu and Wang, Bingjie and Wang, Teng and Zhang, Aijia and Li, Shuang and Chen, Rui and Su, Yanguo and Jiang, Tianze and Zhao, Xia},
title = {Dual Metal Nanoflower Oxygen Pump Microneedles Based on Cuproptosis and STING Pathway Activation for Cancer Immunotherapy},
journal = {Small},
year = {2025},
volume = {21},
number = {11},
doi = {10.1002/smll.202409187}
}
EUVIMED